April 11, 2008Psychiatrist Bans Sales Reps After Seroquel Reps VisitDanny Carlat, whom many of you know through his website and his "Dr. Drug Rep" article of last year, is a clinical professor of psychiatry at Tufts University and is in private practice. Anyhow, Carlat recently had a visit from some AstraZeneca reps, pushing Seroquel for bipolar depression and using some of the most asinine sales patter ever. "Yes, until today, I was seeing reps a few times a month for 5 minute visits in order to keep up on trends in drug company marketing techniques. But today, an Astra Zeneca rep and his district manager came in to push Seroquel for bipolar depression. They came armed with the two studies that won Seroquel its FDA approval. The studies have their limitations, but somehow these reps didn't bring these up." Those studies would be BOLDER I and BOLDER II, which CL Psych and I have had much fun carving up previously. A letter of mine challenging some of the statistics in BOLDER II will be published in the Journal of Clinical Psychopharmacology in June. Back to Carlat: "[W]hat I got was a ridiculous hard sell: 'Dr. Carlat, given this data, would you choose Seroquel over the other atypical antipsychotics for bipolar depression?' I asked them if Astra Zeneca had done any head-to-head studies comparing Seroquel with the others. The rep adopted a pseudo-confused look, and said, 'I'm not even sure that kind of study would be ethical--would the FDA even allow you to compare an approved drug with an unapproved drug?' I pointed out that the FDA, in fact, requires that drugs be compared with placebo, the ultimate in 'unapproved' drugs, and that they deem this ethical enough." His encounter with the reps goes from there. Were these guys so dumb that they didn't know who they were dealing with in advance? Are reps still being taught and using that absurd Zerox sales training dialogue? I was smarter than that when I was a pharma rep 20 years ago. As a result of the visit, Carlat has banned pharma reps from his office. Good for him. I wish other doctors would follow suit. I also wish doctors would be a hell of a lot more skeptical about how they hand out Seroquel. In my opinion, it is not a good drug for anything other than short-term use--and even in short-term use it's pretty nasty stuff. Your mileage may vary, however. I'll leave it at that. Posted by Philip Dawdy at April 11, 2008 12:03 AM
del.icio.us
Digg it
reddit
Comments
The reps I've met were talking pre-planned canned answers when I directed pointed questions at them in the patient waiting area. Taken aback, after realizing I was asking questions [a doctor might?]he shut up. I encountered a AstraZeneca rep in a hospital pushing Seroquel for Borderline. I also recently had a talk w my own psych and suggested they stop handing out Seroquel as samples and consider it a controlled substance; considering the QBALL, and abuse in prisons to start for reason, besides having street value. I do believe we have entered the antipsychotic for all ailments arena and it isn't going to go away. I hope ppl. watch their backs for walking out of offices with MDD with Seroquel or Abilify in their hands. Posted by: Stephany at April 11, 2008 02:01 AMAgree with your remarks, Stephany. I was waiting with a friend who was to see her doctor down in Raleigh the other day. Apparently two reps came in and my friend didn't tell me, fearful for what I might say or do. I guess she made a good choice. Posted by: Sorrowful at April 11, 2008 11:38 AMI won't ever take Seroquel if I can help it, but I know quite a few folks with bipolar disorder who use it as a maintenance medication and say it is the best thing they've found. So I have to think it has its legitimate uses - just not as a first resort. Philip, when you say in your previous post that 2-3% of U.S. children are on antipsychotics, where does that statistic come from? I gather David Healy said something along those lines but where did he get his numbers? If it's true then that is very disturbing - all the more reason to know where the data are coming from. Posted by: Garth at April 11, 2008 12:18 PM"A letter of mine challenging some of the statistics in BOLDER II will be published in the Journal of Clinical Psychopharmacology in June." Congratulations, that's awesome! Post a comment
|
Patient Blogs. Sites.
The Trouble With Spikol
Icarus Project Blog John's Bipolar Stories Seroxat (Paxil) Sufferers Stand Up! Seroxat (Paxil) Secrets The Bipolar View Writhe Safely soulful sepulcher Electro Boy Spiritual Emergency Mental Nurse Deborah Gray Mental Mommy The Splintered Mind bipolar.and.me Nurse Ratched Psych Person Trick Cycling for Beginners depression introspection Salted Lithium Living With A Purple Dog Polar Trippin' Mercurial Scribe Bipolar Chicks Blogging Beyond Meds Off Label Jung At Heart Graphic Truth Joysoup Apesma's Lament Soapy Water Outlaw Psychiatry Empirical Insanity Patient Anonymous Beyond Blue Psych Survivor Postpartum Progress The Happiness Project Finding Optimism The Gimp Parade Midlife and Treachery Secret Life of a Manic-Depressive Psych Tech Going Through Hell
Doctor Blogs. Sites.
Clinical Psych
World of Psychology CorePsych The Last Psychiatrist Carlat Report Blog Intueri Emotional Well-Being Scientific Misconduct Aaron Beck Cognitive Therapy Today Treatment Online Shrink Rap David Healy Dr. Dork NHS Blog Doctor Dr. X's Free Associations Dr. Sanity Anxious Mind Everyone Needs Therapy Counselling Resource
Activists. News.
Charlottesville Prejudice Watch
The Icarus Project MindFreedom AHRP Blog SSRI Stories Healthy Skepticism Psych Rights Treatment Advocacy Center Peter Breggin Schizophrenia News eDrugSearch Blog Nuts R Us News Disapedia WSJ Health Blog Alison Bass
Social Networking. Forums.
Beyond Meds Social Network
Mood Garden Paxil Progress Crazy Boards Forums Psych Central Forums Icarus Project Forums DepressionTribe MySpace Bipolar Group Bipolar World Pendulum.org Bipolar Planet About.com Bipolar
Science. Big Pharma. Ethics.
PharmaLot
Pharma Gossip Science Blogs Mind Hacks GoozNews Integrity in Science Neurophilospohy bioethics.net Drug Wonks Pharma Marketing Blog Pharma's Cutting Edge On Pharma Health Care Renewal
Current Affairs
Buzz Machine
To The People Andrew Sullivan Michelle Malkin Daily Kos Reason's Hit&Run The Agitator Press Think Jim Romenesko Rough Type Gawker The Graphic Truth Tail Rank Huffington Post Instapundit Little Green Footballs Talking Points Memo MoJo Blog
Seattle Stuff
Smoking. Stuff.
|

